Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

An Open-Label Pilot Study Examining the Feasibility, Safety, and Effectiveness of Psilocybin Therapy for Depression in Bipolar II Disorder

To see complete record on, please visit this link

Id: NCT05065294

Organisation Name: University of California, San Francisco

Overal Status: Recruiting

Start Date: January 28, 2022

Last Update: February 1, 2022

Lead Sponsor: University of California, San Francisco

Brief Summary: The purpose of this study is to determine the safety, tolerability, and feasibility of psilocybin therapy in people with Bipolar II Disorder.

  • Bipolar II Disorder

Total execution time in seconds: 0.29233384132385